Stock listing
Organogenesis Holdings Inc.
- Ticker
- Dusseldorf:2PQ
- Asset type
- Stock
- Sector
- Health Technology
- Industry
- Medical Specialties
- Exchange
- Dusseldorf
- Currency
- EUR
About Organogenesis Holdings Inc.
The company specializes in regenerative medicine and advanced wound care solutions. Its innovative products aim to improve patient outcomes in various medical fields.
Latest news from Organogenesis Holdings Inc.
Organogenesis Holdings Inc. to Report Third Quarter of Fiscal Year 2026 Financial Results on November 5, 2026
Oct 12, 2026
Organogenesis Holdings Inc. Reports Second Quarter 2026 Financial Results
Aug 6, 2026
Organogenesis Announces Publication of Peer-Reviewed Clinical Trial Results Demonstrating Clinical Benefit of Affinity™ in the Most Challenging and Complex Venous Leg Ulcers
Jul 27, 2026
Organogenesis Holdings Inc. to Report Second Quarter of Fiscal Year 2026 Financial Results on August 6, 2026
Jul 9, 2026